Redox balance |
Lynam-Lennon, N. et al. |
Oesophageal adenocarcinoma |
Higher basal level of ROS |
[15] |
Wei, Y. et al. |
Non-small cell lung carcinoma |
Lower radiation-induced ROS level |
[19] |
Lynam-Lennon, N. et al. |
Oesophageal adenocarcinoma |
Maintenance of glutathione levels stable post irradiation |
[21] |
Hanot, M. et al. |
Tongue squamous cell carcinoma |
Altered glutathione levels |
[22] |
Chen, X. et al. |
Oesophageal squamous cell carcinoma |
Increased IDH2 expression |
[24] |
Sun, J. et al. |
CHO cells |
MnSOD overexpression |
[20] |
Hirose, K. et al. |
Melanoma |
[25] |
Kalen, A.L. et al. |
Head-and-neck cancers |
[26] |
Fisher, C.J. et al. |
Pancreatic |
[27] |
DNA repair |
Lynam-Lennon, N. et al. |
Oesophageal adenocarcinoma |
Increased repair of radiation-induced DNA damage |
[21] |
Hyun, J. W. et al. |
Leukaemia |
Low OGG1 activity |
[42] |
Ramdzan, Z.M. et al. |
Breast, Lung, Glioblastoma, Colorectal |
CUX1 overexpression |
[46] |
Wang, Y. et al. |
Non-small cell lung carcinoma |
Downregulation of SSBP1 |
[54] |
Roy, K. et al. |
Glioma |
Methylation of the ATM promoter |
[56] |
Squatrito, M. et al. |
Glioblastoma |
Loss of components in the ATM/Chk2/p53 pathway |
[57] |
You, W.C. et al. |
Glioblastoma |
ATAD3A-mediated attenuation of DSB repairs |
[58] |
Apoptosis |
He, Q. et al
|
Oesophageal squamous cell carcinoma |
High LKB1 expression |
[66] |
Wang, Z. et al. |
Mouse embryonic fibroblasts |
MKP1 inhibition of JNK-mediated apoptosis |
[68] |
Candas, D. et al. |
HER2-positive breast cancer |
MKP1 overexpression |
[148] |
Cell cycle checkpoints |
Wei, Y. et al. |
Non-small cell lung carcinoma |
Prolonged G2 arrest |
[19] |
Cloos, C. R. et al. |
Pancreatic |
Supressed G2 activation increased cyclin B1 and CDK1 |
[77] |
Muschel, R. J., et al. |
Cervical cancer |
Altered Cyclin B expression |
[78] |
Liu, R. et al. |
Colon, Glioblastoma, Breast |
Increased SIRT3 activity |
[80] |
Mitochondria-to-nucleus retrograde signaling |
Wei, Y. et al. |
Non-small cell lung carcinoma |
NF-κB/ PI3K/AKT2/mTOR activation |
[19] |
Cloos, C. R. et al. |
Pancreatic cancer |
Mitochondrial DNA depletion |
[77] |
Mitochondrial membrane potential |
Dong, Q. et al. |
Oesophageal carcinoma |
Modulation of BMI-1 expression |
[84] |
Li, Y.L. et al. |
Head and neck cancers |
Increased GDF15 expression |
[85] |
Mitochondrial ion channels |
Huang, L. et al. |
Glioma |
Overexpression of mtKATP channel |
[86] |
Arif, T. et al. |
Breast, lung Glioblastoma |
VDAC1 overexpression |
[14] |
Glycolysis |
Pitroda, S.P. et al. |
Tongue squamous cell carcinoma |
STAT1 regulation of energy metabolism |
[91] |
De Schutter, H. et al. |
Head and neck cancers |
GLUT1 overexpression |
[95] |
Kunkel, M. et al. |
Oral cavity squamous carcinoma |
[96] |
Blatt, S. et al. |
Head and neck cancers |
High levels of lactate |
[97] |
Sandulache, V.C. et al. |
[98] |
Hao, J. et al. |
Prostate |
Increased LDHA |
[99] |
Glutamine metabolism |
Li, D. et al. |
Pancreatic |
Non-canonical glutamine metabolism pathway |
[107] |
Xiang, L. et al. |
Cervical |
Increased GLS2 expression |
[105] |
Oxidative phosphorylation |
Lynam-Lennon et al. |
Oesophageal adenocarcinoma |
Increased ATP5B expression |
[15] |
Le Bleu, V.S. et al. |
Breast |
Increased PGC1α |
[110] |
Viale, A. et al
|
Pancreatic |
Increased expression of OXPHOS genes |
[112] |
Grasso, D. et al. |
Head and neck cancer |
Increased OXPHOS metabolism |
[113] |